Cancer cells compress intratumour vessels
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The delivery of therapeutic drugs to solid tumours may be impaired by structural and functional abnormalities in blood and lymphatic vessels. Here we provide evidence that proliferating cancer cells cause intratumour vessels to compress and collapse. By reducing this compressive mechanical force and opening vessels, cytotoxic cancer treatments have the potential to increase blood perfusion, thereby improving drug delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This results in uneven blood flow within the tumor, generating regions of chronic or intermittent hypoxia and regions of enhanced permeability and increased interstitial pressure, which can result in compression of tumor vessels and poor vascular perfusion, hampering drug delivery [27].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [27]
In the citing paper
“It enhances tumor cell proliferation and builds up a transport barrier to drug delivery, greatly lowering the efficacy of anticancer drugs and therapies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
In the citing paper
“Elevated extracellular stresses have been observed in many tumors[170][171][172][173][174][175][176][177][178].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
Citations
Cites
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Self-citationLymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Self-citationSolid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859
Self-citationMolecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Self-citation(1999) · PubMed · Cited by 348
Self-citationThe Second Valve System in Lymphatics
Schmid‐Schönbein, G. W. (2003) · Lymphatic Research and Biology · doi:10.1089/15396850360495664 · Cited by 113
Solid stress facilitates spheroid formation: potential involvement of hyaluronan
Koike, C., McKee, T. D., Pluen, A., Ramanujan, S., Burton, K., Munn, L. L., Boucher, Y., & Jain, R. K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600158 · Cited by 84
Self-citationImproved microcirculation in irradiated tumours
Reinhold, H. S. (1971) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(71)90069-7 · Cited by 71
Arbiser, J. L., Raab, G., Rohan, R. M., Paul, S., Hirschi, K. K., Flynn, E. A., Price, E. R., Fisher, D. E., Cohen, C., & Klagsbrun, M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65171-1 · Cited by 36
Research works printed but not linked: 2
- Boucher, Y. & Jain, R. K. Cancer Res. 52, 5110–5114 (1992).
- Griffon-Etienne, G., Boucher, Y., Brekken, C., Suit, H. D. & Jain, R. K. Cancer Res. 59, 3776–3782 (1999).
Cited by
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Self-citationTensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
“Tumor rigidity likely reflects an elevation in interstitial tissue pressure and solid stress due to a perturbed vasculature and tumor expansion (Padera et al., 2004), an increase in the elastic modulus of transformed cells mediated by an altered cytoarchitecture (Beil et al., 2003), and matrix…”
BackgroundDelivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
“Finally, proliferating tumor cells and/or stromal cells exert solid stress and compress blood vessels, which might cause vessel collapse”
BackgroundSelf-citationBertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
“The mass of hyperproliferative cancer cells also exert mechanical pressure on the different vessels further impeding perfusion [47].”
BackgroundInfluentialDrug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
“and the compression of blood and lymphatic vessels by cancer cell”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
“Furthermore, the growing tumour cells might compress the vessels, and so further reduce flo”
BackgroundDrug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
“This condition is aggravated by poorly functioning lymphatic vessels, which are compressed by cancer and stromal cell”
BackgroundSelf-citationNormalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Self-citationAntiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
“…blood perfusion and hypoxia in tumors results not only from the abnormal structure and leakiness of tumor vessels, but also from the compression of vessels by extravascular components in tumors (Chauhan et al., 2013, 2014; Jain, 1988, 2014; Padera et al., 2004; Stylianopoulos et al., 2012).”
Self-citationNishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
“In addition, the pressure generated by proliferating cancer cells compresses intratumoral blood and lymphatic vessels and leads to an abnormal microenvironment characterized by an impaired blood supply, interstitial hypertension, hypoxia, and acidosis (Padera et al 2004).”
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
“With tumour growth, cancer cells migrate along blood vessels, compressing and destabilizing them, which leads to vessel regression and reduced perfusio”
BackgroundSelf-citationAligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., & Keely, P. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.076 · Cited by 1,285
Lymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285
“At least in animal models, intratumoural lymphatic vessels may not be completely functional, because these vessels collapse under high intra-tumoural pressur”
BackgroundTumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
“This high pressure also contributes to the compression of blood and lymphatic vessels, further adding to the high IFP, causing blood vessel collapse and inefficient tumor perfusion [39,40].”
BackgroundThe role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
Self-citationNormalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
“and/or hyaluronan), both blood and lymphatic vessels open up (Data Supplement Fig S11).(35,36,134) Other investigators have also”
BackgroundSelf-citationChallenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
“Hence, to improve such situations, encapsulating these small molecules in nanosized drug carriers is routinely carried out to enhance their pharmacokinetics, provide tumor selectivity and reduce side effects [34].”
BackgroundInfluentialThe Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044
“Blood and lymphatic vessel compression reduces the delivery of oxygen, nutrients and drugs, creating a hypoxic and acidic microenvironment and compromising therapeutic outcomes (1, 2, 11-15).”
Self-citationChauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031
“The matrix stores and transmits this stress throughout the tumour 7 , collapsing blood vessels to limit perfusion 8,9 .”
Self-citationErnsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943
“Moreover, the magnitude of the calculated compressive stress—comparable with the magnitude measured in spheroids (31, 32)—was large enough to compress vessels and nearby organs, obstruct large blood vessels with life-threatening consequences, or induce pain by pressing on nerves (18).”
BackgroundSelf-citationNia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
Self-citationStrategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 812
Self-citationCellular abnormalities of blood vessels as targets in cancer
Baluk, P., Hashizume, H., & McDonald, D. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 781
“Structural abnormalities of tumor vessels and high interstitial pressure compromise blood flow and interfere with drug delivery [13 ].”
BackgroundVEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Lohela, M., Bry, M., Tammela, T., & Alitalo, K. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.012 · Cited by 738
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“These areas result from abnormal angiogenesis or from the compression/closing of blood vessels by cancer cells [70].”
BackgroundWiig, H., & Swartz, M. A. (2012) · Physiological Reviews · doi:10.1152/physrev.00037.2011 · Cited by 722
“Other possible factors that may contribute to the high Pif are the lack of functioning lymphatics in central tumor areas (262, 350), intratumoral blood vessel compression due to solid stress from the growing tumor (351), and direct effects of growth factors like PDGF, TGF- , and VEGF (187).”
BackgroundVakoc, B. J., Lanning, R. M., Tyrrell, J. A., Padera, T. P., Bartlett, L. A., Stylianopoulos, T., Munn, L. L., Tearney, G. J., Fukumura, D., Jain, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.1971 · Cited by 719
“Diphtheria toxin accumulates in human cells, halting protein synthesis and eventually inducing apoptosis, but does not affect murine cell”
BackgroundSelf-citationTumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 691
Self-citationMechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Cancer cell motility: lessons from migration in confined spaces
Paul, C. D., Mistriotis, P., & Konstantopoulos, K. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.123 · Cited by 648
Mechanical compression drives cancer cells toward invasive phenotype
Tse, J. M., Cheng, G., Tyrrell, J. A., Wilcox-Adelman, S. A., Boucher, Y., Jain, R. K., & Munn, L. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118910109 · Cited by 631
“Growth-induced mechanical stress accumulates in structural elements of the interstitium and cells and is sufficient to collapse blood and lymphatic vessels (24).”
BackgroundSelf-citationDefining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623
“Thus, reduced pressure can lead to decreased convective forces and increased extravasation of both blood components and nanoparticles [26,28,38].”
BackgroundJain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612
“The lack of functional lymphatics in tumors contributes to the elevated IFP and probably results from compression of these vessels by proliferating cancer cells (11) and/ or impaired lymphatic valves (12).”
BackgroundSelf-citationDelivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
Self-citationMalignant cells facilitate lung metastasis by bringing their own soil
Duda, D. G., Duyverman, A. M. M. J., Kohno, M., Snuderl, M., Steller, E. J. A., Fukumura, D., & Jain, R. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016234107 · Cited by 594
“S1), because human cells are 1,000 times more sensitive to DT than murine cells and can be depleted by DT in vivo in mice (15, 16).”
BackgroundSelf-citationTumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
“Solid (mechanical) stress generated by proliferating tumor cells also compresses vessels in tumors [Padera et al., 2004].”
BackgroundSelf-citationNear-infrared luminescence high-contrast in vivo biomedical imaging
Chen, Y., Wang, S., & Zhang, F. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00002-8 · Cited by 566
Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563
Self-citationNonlinear modelling of cancer: bridging the gap between cells and tumours
Lowengrub, J. S., Frieboes, H. B., Jin, F., Chuang, Y.-L., Li, X., Macklin, P., Wise, S. M., & Cristini, V (2010) · Nonlinearity · doi:10.1088/0951-7715/23/1/r01 · Cited by 553
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
Combining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508
“Diptheria toxin Cancer cells Soft tissue sarcoma ↑ (24) Not reported Taxane Cancer cells Soft tissue sarcoma ↑ (23) Not reported Saridegib Stromal cells Pancreatic ductal carcinoma ↑ (25, 27) ↑ (25, 27) PEGPH20 Hyaluronan Pancreatic ductal carcinoma ↑ (28, 29) ↑ (28, 29) 1D11 Collagen Mammary carcinoma ↑ (30) ↑ (30) L…”
BackgroundSelf-citationJeyaraj, M., Gurunathan, S., Qasim, M., Kang, M.-H., & Kim, J.-H. (2019) · Nanomaterials · doi:10.3390/nano9121719 · Cited by 481
“Previously, several authors have reported that EPR effects increase the drug absorption as well as prolong drug retention [236,238,239].”
BackgroundStylianopoulos, T., Martin, J. D., Snuderl, M., Mpekris, F., Jain, S. R., & Jain, R. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4521 · Cited by 477
“In the interior, the tumor is compressed, which could collapse blood vessels (14), while at the interface with the normal tissue the tumor is compressed in the radial direction and stretched in the circumferential.”
Self-citationCheng, G., Tse, J., Jain, R. K., & Munn, L. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004632 · Cited by 478
“[7].”
Self-citationThe Tension Mounts: Mechanics Meets Morphogenesis and Malignancy
Paszek, M. J., & Weaver, V. M. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-004-1404-x · Cited by 467
“Increased matrix stiffness could influence the behavior of transformed MECs by directly activating mechanotransduction pathways or by indirectly stimulating resident mammary gland stromal fibroblasts to release various cytokines, growth factors and ECM degrading enzymes (71,77,78) .A n increase in resistance could als…”
BackgroundMultifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
““Environmentally-responsive” or “smart” polymeric micelles can release their therapeutic payloads by undergoing structural modifications in response to the stimulus.”
BackgroundPerspectives on biological growth and remodeling
Ambrosi, D., Ateshian, G. A., Arruda, E. M., Cowin, S. C., Dumais, J., Goriely, A., Holzapfel, G. A., Humphrey, J. D., Kemkemer, R., Kuhl, E., et al. (2011) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2010.12.011 · Cited by 460
FUKUMURA, D., DUDA, D. G., MUNN, L. L., & JAIN, R. K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00029.x · Cited by 451
“This is due to the compression of intra-tumor lymphatic vessels by mechanical stress (solid stress) created by tumor cell proliferation in a confined space [121].”
BackgroundSelf-citationSolid stress and elastic energy as measures of tumour mechanopathology
Nia, H. T., Liu, H., Seano, G., Datta, M., Jones, D., Rahbari, N., Incio, J., Chauhan, V. P., Jung, K., Martin, J. D., et al. (2016) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0004 · Cited by 449
“Early evidence for the existence of solid stress in tumours came from our discovery that blood and lymphatic vessels are mechanically compressed [11–13]; this can contribute to hypoxia [9, 14] and promote tumour progression, and lower the efficacy of chemo-, radio-, and immunotherapies [15].”
Self-citationThe tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
“Likewise, compression stress also increases the interstitial pressure, blocking tissue vasculature and lymphatic networks, and impairing drug delivery and immune cell infiltration and clearance (Jain, 2001; Padera et al., 2004).”
BackgroundDudley, A. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006536 · Cited by 424
“Tumor vessels are also squeezed and compressed by overlying tumor cells, which creates biomechanical tension, strain, and changes in blood flow (Padera et al. 2004).”
BackgroundA single-cell-based model of tumor growth in vitro: monolayers and spheroids
Drasdo, D., & Höhme, S. (2005) · Physical Biology · doi:10.1088/1478-3975/2/3/001 · Cited by 421
Engineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Feeling Stress: The Mechanics of Cancer Progression and Aggression
Northcott, J. M., Dean, I. S., Mouw, J. K., & Weaver, V. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00017 · Cited by 409
“In addition to a rigid matrix, integrin clustering can be facilitated by a bulky glycocalyx at the cell surface, which applies tension to matrix-bound integrins (Paszek et al., 2014).”
BackgroundCell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis
Gkretsi, V., & Stylianopoulos, T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00145 · Cited by 390
“As a result, blood vessels can be compressed or totally collapsed, creating large avascular regions within the tumor thus causing hypo-perfusion and hypoxia (58, 95) which ultimately inhibit systemic administration of drugs to the tumors (55, 60) and can promote tumor progression in multiple ways (96).”
BackgroundOverchuk, M., & Zheng, G. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.024 · Cited by 383
Pericytes and vessel maturation during tumor angiogenesis and metastasis
Raza, A., Franklin, M. J., & Dudek, A. Z. (2010) · American Journal of Hematology · doi:10.1002/ajh.21745 · Cited by 382
“Vascular regression could also lead to the normalization of tumor microvessels and the opening of previously collapsed vessels [72] via decreased interstitial fluid pressure [73].”
BackgroundNovel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis
Sluimer, J. C., & Daemen, M. J. (2009) · The Journal of Pathology · doi:10.1002/path.2518 · Cited by 367
“Moreover, lymph vessels in tumours have been shown to collapse [98].”
BackgroundVascular normalization as a therapeutic strategy for malignant and nonmalignant disease.
Goel, S., Wong, A. H.-K., & Jain, R. K. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006486 · Cited by 352
“This leakiness, together with a relative absence of functional intratumoral lymphatic vessels (Padera et al. 2004; Hagendoorn et al. 2006), leads to a marked increase in the tumor interstitial fluid pressure (IFP) to a level that equilibrates with intravascular pressure, which results in reduced…”
BackgroundInfluentialSelf-citationSuperior Penetration and Retention Behavior of 50 nm Gold Nanoparticles in Tumors
Huo, S., Ma, H., Huang, K., Liu, J., Wei, T., Jin, S., Zhang, J., He, S., & Liang, X.-J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2071 · Cited by 337
“In solid tumors, the microenvironment was complicated, with poorly organized vascular architecture, hypoxia, and increased interstitial fluid pressure as well as the presence of the extracellular matrix (ECM; refs.”
BackgroundInfluentialNanopreparations to overcome multidrug resistance in cancer
Patel, N. R., Pattni, B. S., Abouzeid, A. H., & Torchilin, V. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.004 · Cited by 333
“Furthermore, the tumor cells also compress the blood vessels, which exacerbates the problem [64].”
BackgroundHyaluronan, fluid pressure, and stromal resistance in pancreas cancer
Provenzano, P. P., & Hingorani, S. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.569 · Cited by 323
“The investigators concluded that IFP cannot collapse vessels and that, instead, vascular collapse is caused by SS from proliferating cancer cells (Boucher and Jain, 1992; Padera et al, 2004).”
BackgroundForcing form and function: biomechanical regulation of tumor evolution
Yu, H., Mouw, J. K., & Weaver, V. M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.015 · Cited by 321
Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current Progress
Dong, X., & Mumper, R. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.35 · Cited by 317
Tissue mechanics regulate brain development, homeostasis and disease
Barnes, J. M., Przybyla, L., & Weaver, V. M. (2017) · Journal of Cell Science · doi:10.1242/jcs.191742 · Cited by 316
“…on which tumor cells can migrate and (iii) by compromising blood vessel integrity, which can influence both the recruitment of inflammatory cells and the permeability of macromolecules, including therapeutic compounds (Netti et al., 2000; Jain, 1999; Pickup et al., 2014; Padera et al., 2004).”
BackgroundThree-dimensional context regulation of metastasis
Erler, J. T., & Weaver, V. M. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9209-8 · Cited by 313
“Tumor stiffness has additionally been attributed to the elevated interstitial pressure due to leaky blood vessels and lymphatics [88].”
BackgroundMR Elastography of Liver Tumors: Preliminary Results
Venkatesh, S. K., Yin, M., Glockner, J. F., Takahashi, N., Araoz, P. A., Talwalkar, J. A., & Ehman, R. L. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3123 · Cited by 312
“Tumor rigidity probably reflects an elevation in interstitial tissue pressure and solid stress due to altered vasculature and tumor expansion [25], an increase in the elastic modulus of transformed cells mediated by an altered cytoarchitecture [26], and matrix stiffening linked to fibrosis [24].”
BackgroundSorensen, A. G., Emblem, K. E., Polaskova, P., Jennings, D., Kim, H., Ancukiewicz, M., Wang, M., Wen, P. Y., Ivy, P., Batchelor, T. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2464 · Cited by 295
“Killing of cancer cells surrounding blood vessels can open up compressed blood vessels, and in turn, also increase blood perfusion (17).”
Self-citationCombining microenvironment normalization strategies to improve cancer immunotherapy
Mpekris, F., Voutouri, C., Baish, J. W., Duda, D. G., Munn, L. L., Stylianopoulos, T., & Jain, R. K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919764117 · Cited by 286
Self-citationManohar, S., Vaartjes, S. E., van Hespen, J. C. G., Klaase, J. M., van den Engh, F. M., Steenbergen, W., & van Leeuwen, T. G. (2007) · Optics Express · doi:10.1364/oe.15.012277 · Cited by 287
In situ force mapping of mammary gland transformation
Lopez, J. I., Kang, I., You, W.-K., McDonald, D. M., & Weaver, V. M. (2011) · Integrative Biology · doi:10.1039/c1ib00043h · Cited by 284
Hypoxia Positron Emission Tomography Imaging With 18F-Fluoromisonidazole
Lee, S. T., & Scott, A. M. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.07.001 · Cited by 283
Current Applications of Nanoemulsions in Cancer Therapeutics
Sánchez-López, E., Guerra, M., Dias-Ferreira, J., Lopez-Machado, A., Ettcheto, M., Cano, A., Espina, M., Camins, A., Garcia, M. L., & Souto, E. B. (2019) · Nanomaterials · doi:10.3390/nano9060821 · Cited by 276
Pearce, A. K., & O’Reilly, R. K. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00456 · Cited by 275
Engineering and physical sciences in oncology: challenges and opportunities
Mitchell, M. J., Jain, R. K., & Langer, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.83 · Cited by 273
Self-citationLymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?
Wong, S. Y., & Hynes, R. O. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2646 · Cited by 266
Nanosystem drug targeting: Facing up to complex realities
Ruenraroengsak, P., Cook, J. M., & Florence, A. T. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.032 · Cited by 265
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264
“Continuous unregulated tumor proliferation in this enclosed space then compresses blood and lymphatic vessels due to growth induced solid stress, which in turn prevents the efficient discharge both NP and interstitial fluid from the tumor [1, 83, 84].”
BackgroundPassaro, D., Di Tullio, A., Abarrategi, A., Rouault-Pierre, K., Foster, K., Ariza-McNaughton, L., Montaner, B., Chakravarty, P., Bhaw, L., Diana, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.001 · Cited by 258
“Second, the mean vascular diameter of vessels was reduced (Figure 1E), a pathologic phenotype previously reported in tumor angiogenesis as a result of solid stress applied to vessels by overgrowing tumor cells (Padera et al., 2004; Stylianopoulos and Jain, 2013).”
BackgroundMierke, C. T. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab1628 · Cited by 262
Fluid shear stress activates YAP1 to promote cancer cell motility
Lee, H. J., Diaz, M. F., Price, K. M., Ozuna, J. A., Zhang, S., Sevick-Muraca, E. M., Hagan, J. P., & Wenzel, P. L. (2017) · Nature Communications · doi:10.1038/ncomms14122 · Cited by 258
“In early lymphatic metastasis, it has been suggested that passive intravasation can occur when primary tumour cells growing in a confined space push against each other, producing stress that can collapse lymphatic vessels and, potentially, force cells to breach fragile lymphatic vessels 48,49 .”
Sajja, H., East, M., Mao, H., Wang, Y., Nie, S., & Yang, L. (2009) · Current Drug Discovery Technologies · doi:10.2174/157016309787581066 · Cited by 250
“Proliferating cancer cells can cause intratumoral vessels to compress and collapse [87].”
BackgroundSPARC and tumor growth: Where the seed meets the soil?
Framson, P. E., & Sage, E. H. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20091 · Cited by 249
“…many types of tumors exhibit a reciprocity with respect to these criteria and respond in kind with altered properties of adhesion (cell–cell or cell–ECM), motility, and proliferation, facilitated in part by aberrant ECM structure or composition and a compromised vasculature [Padera et al., 2004].”
BackgroundBockhorn, M., Jain, R. K., & Munn, L. L. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70140-7 · Cited by 244
Self-citationCancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 244
Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications
Mosayebi, J., Kiyasatfar, M., & Laurent, S. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700306 · Cited by 241
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
Greish, K., Nehoff, H., Parayath, N., Domanovitch, L., & Taurin, S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s47129 · Cited by 238
“11 Finally, IFP is also increased as a response to contraction of the interstitial space, an effect mediated by stromal fibroblasts.”
Cycling hypoxia: A key feature of the tumor microenvironment
Michiels, C., Tellier, C., & Feron, O. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.004 · Cited by 237
Computer simulation of glioma growth and morphology
Frieboes, H. B., Lowengrub, J. S., Wise, S., Zheng, X., Macklin, P., Bearer, E. L., & Cristini, V. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.03.008 · Cited by 234
“As the tumor grows and engulfs vessels in its vicinity, the tumor may compress the vessels (Padera et al., 2004) and disrupt flow of nutrients, leading to further necrosis and even temporary mass and vascular regression (Zagzag et al., 2000, Holash et al., 1999b).”
BackgroundWu, M., Frieboes, H. B., McDougall, S. R., Chaplain, M. A. J., Cristini, V., & Lowengrub, J. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.11.031 · Cited by 229
“Further, here we incorporated the vessel collapse by tumor stress (Padera et al., 2004) using vessel radii adaption model by Pries et al.”
BackgroundMethod
Metadata
- Authors
- Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Jain, Rakesh K.
- Venue
- Nature
- Published
- 2004-02-19
- Volume
- 427
- Issue
- 6976
- Pages
- 695-695
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2014282546
- Cited by
- 857
- References
- 10
- Citations by year
- 2026: 28 · 2025: 48 · 2024: 40 · 2023: 47 · 2022: 39 · 2021: 44 · 2020: 48 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 48 · 2015: 32 · 2014: 36 · 2013: 39 · 2012: 42
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor vasculature, tumor cell proliferation, vascular collapse, mechanical forces, lymphatic vessels, cytotoxic chemotherapy
- MeSH terms
- Animals, Cell Division, Diphtheria Toxin, Humans, Neoplasm Transplantation, Neoplasms, Transplantation, Heterologous, Reperfusion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.